![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
* Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, PA
4 To whom correspondence should be addressed. E-mail: jjefferson{at}psu.edu.
ABSTRACT
BCAAs stimulate protein synthesis in in vitro preparations of skeletal muscle. Likewise, the stimulation of protein synthesis in skeletal muscle produced by intake of a mixed meal is due largely to BCAAs. Of the three BCAAs, leucine is the one primarily responsible for the stimulation of protein synthesis under these circumstances. The stimulatory effect of leucine on protein synthesis is mediated through upregulation of the initiation of mRNA translation. A number of mechanisms, including phosphorylation of ribosomal protein S6 Kinase, eukaryotic initiation factor (eIF)4E binding protein-1, and eIF4G, contribute to the effect of leucine on translation initiation. These mechanisms not only promote global translation of mRNA but also contribute to processes that mediate discrimination in the selection of mRNA for translation. A key component in a signaling pathway controlling these phosphorylation-induced mechanisms is the protein kinase, termed the mammalian target of rapamycin (mTOR). The activity of mTOR toward downstream targets is controlled in part through its interaction with the regulatory-associated protein of mTOR (known as raptor) and the G protein ß-subunit-like protein. Signaling through mTOR is also controlled by upstream members of the pathway such as the Ras homolog enriched in brain (Rheb), a GTPase that activates mTOR, and tuberin (also known as TSC2), a GTPase-activating protein, which, with its binding partner hamartin (also known as TSC1), acts to repress mTOR. Candidates for mediating the action of leucine to stimulate signaling through the mTOR pathway include TSC2, Rheb, and raptor. The current state of our understanding of how leucine acts on these signaling pathways and molecular mechanisms to stimulate protein synthesis in skeletal muscle is summarized in this article.
KEY WORDS: • leucine • mRNA translation • mammalian target of rapamycin • insulin-like growth factor-1
This article has been cited by other articles:
|
|
 |
|
  P. B. Pencharz, R. Elango, and R. O. Ball An Approach to Defining the Upper Safe Limits of Amino Acid Intake J. Nutr., October 1, 2008; 138(10): 1996S - 2002S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Seiliez, J.-C. Gabillard, S. Skiba-Cassy, D. Garcia-Serrana, J. Gutierrez, S. Kaushik, S. Panserat, and S. Tesseraud An in vivo and in vitro assessment of TOR signaling cascade in rainbow trout (Oncorhynchus mykiss) Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R329 - R335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O Schakman, H Gilson, and J P Thissen Mechanisms of glucocorticoid-induced myopathy J. Endocrinol., April 1, 2008; 197(1): 1 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Yang, C. Yang, A. Farberman, T. C. Rideout, C. F. M. de Lange, J. France, and M. Z. Fan The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth J Anim Sci, April 1, 2008; 86(14_suppl): E36 - E50. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Biolo, M. Stulle, F. Bianco, G. Mengozzi, R. Barazzoni, A. Vasile, G. Panzetta, and G. Guarnieri Insulin action on glucose and protein metabolism during L-carnitine supplementation in maintenance haemodialysis patients Nephrol. Dial. Transplant., March 1, 2008; 23(3): 991 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wang and C. G. Proud A Novel Mechanism for the Control of Translation Initiation by Amino Acids, Mediated by Phosphorylation of Eukaryotic Initiation Factor 2B Mol. Cell. Biol., March 1, 2008; 28(5): 1429 - 1442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Kimball, A. N. D. Do, L. Kutzler, D. R. Cavener, and L. S. Jefferson Rapid Turnover of the mTOR Complex 1 (mTORC1) Repressor REDD1 and Activation of mTORC1 Signaling following Inhibition of Protein Synthesis J. Biol. Chem., February 8, 2008; 283(6): 3465 - 3475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. C. Dreyer, E. L. Glynn, H. L. Lujan, C. S. Fry, S. E. DiCarlo, and B. B. Rasmussen Chronic paraplegia-induced muscle atrophy downregulates the mTOR/S6K1 signaling pathway J Appl Physiol, January 1, 2008; 104(1): 27 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Eckert, F. D. Houghton, J. A. Hawkhead, A. H. Balen, H. J. Leese, H. M. Picton, I. T. Cameron, and T. P. Fleming Human embryos developing in vitro are susceptible to impaired epithelial junction biogenesis correlating with abnormal metabolic activity Hum. Reprod., August 1, 2007; 22(8): 2214 - 2224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Lang, R. A. Frost, and T. C. Vary Regulation of muscle protein synthesis during sepsis and inflammation Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E453 - E459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Jeyapalan, R. A. Orellana, A. Suryawan, P. M. J. O'Connor, H. V. Nguyen, J. Escobar, J. W. Frank, and T. A. Davis Glucose stimulates protein synthesis in skeletal muscle of neonatal pigs through an AMPK- and mTOR-independent process Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E595 - E603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fujita, H. C. Dreyer, M. J. Drummond, E. L. Glynn, J. G. Cadenas, F. Yoshizawa, E. Volpi, and B. B. Rasmussen Nutrient signalling in the regulation of human muscle protein synthesis J. Physiol., July 15, 2007; 582(2): 813 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Frost and C. H. Lang Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass J Appl Physiol, July 1, 2007; 103(1): 378 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Morrison, X. Xi, C. L. White, J. Ye, and R. J. Martin Amino acids inhibit Agrp gene expression via an mTOR-dependent mechanism Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E165 - E171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, K. Guo, R. E. LeBlanc, D. Loh, G. J. Schwartz, and Y.-H. Yu Increasing Dietary Leucine Intake Reduces Diet-Induced Obesity and Improves Glucose and Cholesterol Metabolism in Mice via Multimechanisms Diabetes, June 1, 2007; 56(6): 1647 - 1654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Hayashi and C. G. Proud The rapid activation of protein synthesis by growth hormone requires signaling through mTOR Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1647 - E1655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pospisilova, J. Cmejlova, J. Hak, T. Adam, and R. Cmejla Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine Haematologica, May 1, 2007; 92(5): e66 - e67. [Full Text] [PDF]
|
|
|
|
|
|
L. Wang, C. J. Rhodes, and J. C. Lawrence Jr. Activation of Mammalian Target of Rapamycin (mTOR) by Insulin Is Associated with Stimulation of 4EBP1 Binding to Dimeric mTOR Complex 1 J. Biol. Chem., August 25, 2006; 281(34): 24293 - 24303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Cynober Introduction to the 5th Amino Acid Assessment Workshop. J. Nutr., June 1, 2006; 136(6 Suppl): 1633S - 1635S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Cynober and R. A. Harris Symposium on Branched-Chain Amino Acids: Conference Summary J. Nutr., January 1, 2006; 136(1): 333S - 336S. [Full Text] [PDF]
|
|
